Alpa Laboratories Ltd Share Price & Stock Analysis

Alpa Laboratories Ltd (NSE: ALPA, BSE: 532878) is an Indore, Madhya Pradesh-based company in the Pharmaceuticals industry. With a market capitalisation of ₹121 Cr, it ranks #3,092 by market cap among the 6,197 Indian listed companies on FinBizNet, and #43 of 63 in Pharmaceuticals. At ₹55.57 (as of 16 Nov 2026), the share price is 39.9% below its 52-week high of ₹92.50 and 20.5% above its 52-week low of ₹46.10. The share price is down 35.7% over one year and down 15.0% over three months.

Key Metrics

Current Price₹55.57
Market Cap₹121 Cr
NSE SymbolALPA
BSE Code532878
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio7.9
Return on Equity8.39%
Return on Assets0.32%
52-Week Range₹46.10 – ₹92.50
1-Year Price Change-35.7%
3-Month Price Change-15.0%
Beta (1Y)0.97
HeadquartersIndore, Madhya Pradesh
Websitewww.alpalabs.in

Latest Quarterly Results — Q2 FY27

Revenue₹31 Cr
Net Profit₹-2 Cr
Net Margin-6.0%
EPS (Basic)₹-0.85
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Alpa Laboratories Ltd Quarterly Revenue and Profit Trend

Alpa Laboratories Ltd reported revenue of ₹31 Cr in Q2 FY27, up 18.0% from ₹26 Cr in Q2 FY26 and up 29.5% from ₹24 Cr in Q1 FY27. It posted a net loss of ₹2 Cr for the quarter, against a net profit of ₹0 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹19 Cr (Q1 FY26) to ₹40 Cr (Q4 FY25). The company reported a net loss in 2 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹31 Cr−₹2 Cr−6.0%
Q1 FY27₹24 Cr₹1 Cr4.1%
Q4 FY26₹31 Cr₹1 Cr4.4%
Q3 FY26₹29 Cr₹2 Cr6.5%
Q2 FY26₹26 Cr₹0 Cr0.4%
Q1 FY26₹19 Cr₹12 Cr61.6%
Q4 FY25₹40 Cr−₹2 Cr−5.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 57.19% of Alpa Laboratories Ltd's shares as of Sept 2026, against 57.29% in Sept 2025 (−0.10 percentage points). Delivery averaged 66.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Alpa Laboratories Ltd

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.

Products and Services

1. Drugs and Chemicals-This segment manufactures and markets pharmaceutical formulations under its own brand and for various pharmaceutical companies. It offers various products for human use and veterinary products.

Business Segments

1. Drugs and Chemicals-100%

Alpa Laboratories Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Alpa Laboratories Ltd₹121 Cr7.98.39%₹31 Cr-35.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Alpa Laboratories Ltd?

Alpa Laboratories Ltd is trading at ₹55.57, with a market capitalisation of ₹121 Cr.

Which sector does Alpa Laboratories Ltd belong to?

Alpa Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Alpa Laboratories Ltd?

Alpa Laboratories Ltd has a P/E of 7.9 and a return on equity of 8.39%.

What is the stock symbol of Alpa Laboratories Ltd?

Alpa Laboratories Ltd is listed on the NSE under the symbol ALPA and on the BSE under the scrip code 532878.

How has Alpa Laboratories Ltd's share price moved over the past year?

Alpa Laboratories Ltd's share price is down 35.7% over one year and down 15.0% over three months. Its 52-week range is ₹46.10 to ₹92.50.

What were Alpa Laboratories Ltd's latest quarterly results?

In Q2 FY27, Alpa Laboratories Ltd reported revenue of ₹31 Cr and net profit of ₹-2 Cr, with basic EPS of ₹-0.85 (consolidated, parsed from the company's exchange filing).

How have Alpa Laboratories Ltd's revenue and profit changed over the past year?

Alpa Laboratories Ltd reported revenue of ₹31 Cr in Q2 FY27, up 18.0% from ₹26 Cr in Q2 FY26 and up 29.5% from ₹24 Cr in Q1 FY27.

What is the promoter holding in Alpa Laboratories Ltd?

Promoters held 57.19% of Alpa Laboratories Ltd's shares as of Sept 2026, against 57.29% in Sept 2025 (−0.10 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.